ZHANG, Y.; TANG, Y.-J.; MAN, Y.; PAN, F.; LI, Z.-H.; JIA, L.-S.
January 2013
International Journal of Immunopathology & Pharmacology;Jan-Mar2013, Vol. 26 Issue 1, p179
Academic Journal
No abstract available.


Related Articles

  • The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target. Paccez, J D; Vasques, G J; Correa, R G; Vasconcellos, J F; Duncan, K; Gu, X; Bhasin, M; Libermann, T A; Zerbini, L F // Oncogene;2/7/2013, Vol. 32 Issue 6, p689 

    Deregulation of the receptor tyrosine kinase Axl has been implicated in the progression of several human cancers. However, the role of Axl in prostate cancer remains poorly understood, and the therapeutic efficacy of Axl targeting remains untested. In this report we identified Axl as a new...

  • Axl Promotes Cutaneous Squamous Cell Carcinoma Survival through Negative Regulation of Pro-Apoptotic Bcl-2 Family Members. Papadakis, Emmanouil S.; Cichoń, Monika A.; Vyas, Jashmin J.; Patel, Nakul; Ghali, Lucy; Cerio, Rino; Storey, Alan; O'Toole, Edel A. // Journal of Investigative Dermatology;Feb2011, Vol. 131 Issue 2, p509 

    Expression of Axl, a receptor tyrosine kinase, is increased in cutaneous squamous cell carcinoma (SCC). Examination of a series of cutaneous SCC tumors revealed positive phospho-Akt (P-Akt) staining accompanied by weak TUNEL staining in Axl-positive tumors, suggesting an anti-apoptotic role for...

  • AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas. May, Caitlin D.; Garnett, Jeannine; XiaoYan Ma; Landers, Sharon M.; Ingram, Davis R.; Demicco, Elizabeth G.; Al Sannaa, Ghadah A.; Vu, Tona; Lixia Han; Yi Zhang; Kivlin, Christine M.; Bolshakov, Svetlana; Kalam, Azad Abul; Juehui Liu; Fuguo Zhou; Broccoli, Dominique; Wei-Lien Wang; Lazar, Alexander J.; Pollock, Raphael E.; Lev, Dina // BMC Cancer;11/14/2015, Vol. 15, p1 

    Background: AXL is a well-characterized, protumorigenic receptor tyrosine kinase that is highly expressed and activated in numerous human carcinomas and sarcomas, including aggressive subtypes of liposarcoma. However, the role of AXL in the pathogenesis of well-differentiated...

  • FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells. Weiguo Liu; David A. Bloom; William G. Cance; Elena V. Kurenova; Vita M. Golubovskaya; Steven N. Hochwald // Carcinogenesis;Jun2008, Vol. 29 Issue 6, p1096 

    Pancreatic cancer is a lethal disease accounting for the fourth leading cause of cancer death in USA. Focal adhesion kinase (FAK) and the insulin-like growth factor-I receptor (IGF-1R) are tyrosine kinases that activate common pathways, leading to increased proliferation and cell survival....

  • Role of Protein Tyrosine Phosphatase Non-Receptor Type 7 in the Regulation of TNF-α Production in RAW 264.7 Macrophages. Seo, Huiyun; Lee, In-Seon; Park, Jae Eun; Park, Sung Goo; Lee, Do Hee; Park, Byoung Chul; Cho, Sayeon // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Protein tyrosine phosphatases play key roles in a diverse range of cellular processes such as differentiation, cell proliferation, apoptosis, immunological signaling, and cytoskeletal function. Protein tyrosine phosphatase non-receptor type 7 (PTPN7), a member of the phosphatase family,...

  • Cross-Phosphorylation, Signaling and Proliferative Functions of the Tyro3 and Axl Receptors in Rat2 Cells. Brown, Jessica E.; Krodel, Meredith; Pazos, Mauricio; Cary Lai; Prieto, Anne L. // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    The dysregulation of receptor protein tyrosine kinase (RPTK) function can result in changes in cell proliferation cell growth and metastasis leading to malignant transformation. Among RPTKs the TAM receptor family composed of three members Tyro3 Axl and Mer has been recognized to have a...

  • Tyrosine Kinase Update: Role and Response in Cancer Therapy. Irby, Rosalyn B.; Jiang, Yixing // Current Cancer Therapy Reviews;2011, Vol. 7 Issue 2, p155 

    For the past several decades, the understanding of the molecular mechanisms of cancer initiation, progression, and metastasis has increased. As data elucidating these mechanisms has been amassed, potential targets for therapy have been identified. Tyrosine kinases were first recognized in 1979...

  • Sunitinib malate (SU-11248) reduces tumour burden and lung metastasis in an intratibial human xenograft osteosarcoma mouse model. Kumar, Ram Mohan Ram; Arlt, Matthias J. E.; Kuzmanov, Aleksandar; Born, Walter; Fuchs, Bruno // American Journal of Cancer Research;2015, Vol. 5 Issue 7, p2156 

    Osteosarcoma is a rare type of cancer that commonly occurs as a primary bone tumour in children and adolescents and is associated with a poor clinical outcome. Despite complex treatment protocols, including chemotherapy combined with surgical resection, the prognosis for patients with...

  • Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival. Ammoun, S; Provenzano, L; Zhou, L; Barczyk, M; Evans, K; Hilton, D A; Hafizi, S; Hanemann, C O // Oncogene;1/16/2014, Vol. 33 Issue 3, p336 

    TAM family receptor tyrosine kinases comprising Tyro3 (Sky), Axl, and Mer are overexpressed in some cancers, correlate with multidrug resistance and contribute to tumourigenesis by regulating invasion, angiogenesis, cell survival and tumour growth. Mutations in the gene coding for a tumour...

  • β-Catenin is required for Ron receptor-induced mammary tumorigenesis. Wagh, P K; Gray, J K; Zinser, G M; Vasiliauskas, J; James, L; Monga, S P; Waltz, S E // Oncogene;8/25/2011, Vol. 30 Issue 34, p3694 

    Our previous studies demonstrated that selective overexpression of the Ron receptor tyrosine kinase in the murine mammary epithelium leads to mammary tumor formation. Biochemical analysis of mammary tumor lysates showed that Ron overexpression was associated with increases in β-catenin...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics